Regulatory
The Nominating Committee at Sleep Cycle appointed
The nominating committee for Sleep Cycle AB’s Annual General Meeting 2022, has been appointed by the company's three largest shareholders, or shareholder groups, with each selecting a representative to the nominating committee.Sleep Cycle interim report January-June 2021: Continued growth coupled with increased investments in marketing, headcount and stock exchange listing
During the second quarter the number of subscribers continued to grow to a total of 852k, an increase of 14.5%. Net revenues increased by 12.5%, corresponding to 20.3% adjusted currency. Growth was driven by high renewal rates, effective investment in marketing and new growth initiatives such as B2B sales and partnership programs. Increased spend on marketing, a growing organization and the stock exchange listing contributed to a planned increase in costs and therefore a decline in net income for this quarter.Exercise of the over-allotment option in the IPO of Sleep Cycle
Skandinaviska Enskilda Banken AB (publ) (”SEB” or the “Joint Global Coordinator”) has today notified Sleep Cycle AB (publ) (“Sleep Cycle” or the “Company”) and the selling shareholders (GLA Invest S A, MCGA AB, h265 AB and Petter Wallin) (the “Selling Shareholders”) that the over-allotment option has been exercised in full and that the stabilisation period has ended.Number of shares and votes in Sleep Cycle
The number of shares and votes in Sleep Cycle AB (publ) (“Sleep Cycle”) have changed as a result of the issue of shares carried out in connection with the listing of Sleep Cycle’s shares on Nasdaq Stockholm on 8 June 2021.Trading in Sleep Cycle AB’s (publ) shares on Nasdaq Stockholm commences today
Sleep Cycle AB (publ) ("Sleep Cycle” or the "Company”), a market leading[1] sleep tracking application with a mission to empower people to sleep better to improve global health, today announces the outcome of the initial public offering of Sleep Cycle’s shares and the listing on Nasdaq Stockholm (the “Offering”). The Offering attracted strong interest from Swedish and international institutional investors and the general public in Sweden. As a result of the Offering, Sleep Cycle will have more than 6,000 shareholders.Sleep Cycle AB (publ) publishes prospectus and announces the price of its initial public offering on Nasdaq Stockholm
Following the announcement of its intention to float on 19 May 2021, Sleep Cycle AB (publ) (”Sleep Cycle” or the ”Company”), a market leading sleep tracking application, today publishes its prospectus and announces the price for the offering (the “Offering”) and listing of its shares on Nasdaq Stockholm. The first day of trading is expected to be 8 June 2021.Sleep Cycle AB (publ) intends to list its shares on Nasdaq Stockholm
Gothenburg, Sweden - May 19, 2021Sleep Cycle AB (publ) (“Sleep Cycle” or the “Company”), a market leading sleep tracking application, hereby announces its intention to launch an initial public offering of its shares (the "IPO" or the ”Offering”) and to list its shares on Nasdaq Stockholm. The Offering is expected to consist of existing shares in the Company offered by the Selling Shareholders (as defined below) and newly issued shares.